Side-by-side comparison of AI visibility scores, market position, and capabilities
Embedded business financing platform enabling platforms to offer capital to their SMB users. San Francisco CA, raised $93M+, partners with DoorDash, Amazon, and other platforms.
Parafin is an embedded business financing platform that enables software platforms and marketplaces to offer capital advances and loans to their small business users. Founded in 2020 and headquartered in San Francisco, California, the company has raised over $93 million in funding. Parafin's model is B2B2B — it partners with large platforms like DoorDash, Amazon, and others to offer those platforms' small business customers access to working capital, with repayment tied to the platform's revenue flow.\n\nParafin's revenue-based financing model uses the platform partner's transaction data to underwrite SMB customers without requiring extensive paperwork or traditional bank credit checks. Repayments are automatically deducted as a percentage of each payment the SMB receives through the platform, creating a repayment structure that flexes with business performance. This approach reduces default risk while making capital accessible to SMBs that might not qualify for traditional bank loans.\n\nParafin's embedded distribution model — reaching SMBs through their existing platform relationships rather than direct marketing — gives it a significant customer acquisition advantage over standalone SMB lenders. Platform partners benefit by offering a valued financial service to their merchants or sellers, increasing platform stickiness and creating a new revenue stream through referral economics. Parafin handles underwriting, compliance, capital markets, and servicing, making the integration minimal for platform partners.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.